These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36465578)

  • 1. A Friend or a Foe? Bariatric Surgery in Chronic Kidney Disease: A Case Report.
    Bagai S; Bansal B; Malik V; Prasad P; Khullar D
    Case Rep Nephrol Dial; 2022; 12(3):207-211. PubMed ID: 36465578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric Surgery in Patients with a History of Nephrolithiasis: 24-h Urine Profiles and Radiographic Changes After Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy.
    Uy M; Di Lena R; Hoogenes J; Alharbi B; Gmora S; Shayegan B; Matsumoto ED
    Obes Surg; 2021 Apr; 31(4):1673-1679. PubMed ID: 33387265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Sanguankeo A
    Surg Obes Relat Dis; 2016; 12(8):1513-1521. PubMed ID: 27396545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.
    Maalouf NM; Tondapu P; Guth ES; Livingston EH; Sakhaee K
    J Urol; 2010 Mar; 183(3):1026-30. PubMed ID: 20096421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass.
    Agrawal V; Wilfong JB; Rich CE; Gibson PC
    Case Rep Nephrol Dial; 2016; 6(3):114-119. PubMed ID: 27781207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of oxalate nephropathy in a kidney transplant recipient with prior gastric bypass surgery.
    Sørensen CG; Hvas CL; Thomsen IM; Jespersen B
    Clin Kidney J; 2021 May; 14(5):1478-1480. PubMed ID: 34221374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.
    Nasr SH; D'Agati VD; Said SM; Stokes MB; Largoza MV; Radhakrishnan J; Markowitz GS
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1676-83. PubMed ID: 18701613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Beauty and the Beast: Bariatric Surgery and a Case of Oxalate Nephropathy.
    Carvalho R; Medeiros J; Ribeiro B; Bastos JM; Vaz R
    Cureus; 2023 Mar; 15(3):e36801. PubMed ID: 37123725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery.
    Sinha MK; Collazo-Clavell ML; Rule A; Milliner DS; Nelson W; Sarr MG; Kumar R; Lieske JC
    Kidney Int; 2007 Jul; 72(1):100-7. PubMed ID: 17377509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Management of Advanced Oxalate Nephropathy Secondary to Gastric Bypass Surgery.
    Kamel TH; Maroz N
    Am J Med Sci; 2021 Apr; 361(4):517-521. PubMed ID: 33187632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.
    Canales BK; Ellen J; Khan SR; Hatch M
    J Urol; 2013 Sep; 190(3):1102-9. PubMed ID: 23499748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrolithiasis after bariatric surgery: A review of pathophysiologic mechanisms and procedural risk.
    Bhatti UH; Duffy AJ; Roberts KE; Shariff AH
    Int J Surg; 2016 Dec; 36(Pt D):618-623. PubMed ID: 27847289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass.
    Penniston KL; Kaplon DM; Gould JC; Nakada SY
    J Urol; 2009 Nov; 182(5):2340-6. PubMed ID: 19762051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bariatric surgery, hyperoxaluria, and nephrolithiasis: a plea for close postoperative management of risk factors.
    Kleinman JG
    Kidney Int; 2007 Jul; 72(1):8-10. PubMed ID: 17597787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery.
    Park AM; Storm DW; Fulmer BR; Still CD; Wood GC; Hartle JE
    J Urol; 2009 Nov; 182(5):2334-9. PubMed ID: 19762043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
    Kumar R; Lieske JC; Collazo-Clavell ML; Sarr MG; Olson ER; Vrtiska TJ; Bergstralh EJ; Li X
    Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrolithiasis after bariatric surgery for obesity.
    Lieske JC; Kumar R; Collazo-Clavell ML
    Semin Nephrol; 2008 Mar; 28(2):163-73. PubMed ID: 18359397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.
    Duffey BG; Alanee S; Pedro RN; Hinck B; Kriedberg C; Ikramuddin S; Kellogg T; Stessman M; Moeding A; Monga M
    J Am Coll Surg; 2010 Jul; 211(1):8-15. PubMed ID: 20610243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.